Newsroom

Sera announced financial results for the third quarter of 2024 ended September 30, 2024.

Sera announced that it will report third quarter fiscal year 2024 financial results on Wednesday, November 6, 2024

Sera announced that the company will present at the H.C. Wainwright Global Investment Conference on Wednesday, September 11, 2024 at 10:00 a.m. ET

Zhenya Lindgardt, will participate in a panel discussion: Future of Genetic Testing – Babies and Beyond, on August 14 at 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time.

Sera announced financial results for the second quarter of 2024 ended June 30, 2024.

Sera announced that it will report second quarter fiscal year 2024 financial results on Wednesday, August 7, 2024, after the close of the market.

Sera Announces Publication of Positive AVERT PRETERM TRIAL Results in the International Peer-Reviewed Journal, Diagnostics

Sera announced that as a result of the annual Rusell Reconstitution being finalized on June 28, 2024, the Company has been added to the Russell Small-Cap 2000 and Russell 3000 indexes

Sera announced that it has been added to the preliminary list of the Russell Small-Cap 2000 and Russell 3000 indexes

Sera announced financial results for the first quarter of 2024 ended March 31, 2024.